# A Study to Evaluate the Safety and Tolerability of Tecarfarin in Healthy Chinese Volunteers

> **NCT03652779** · PHASE1 · COMPLETED · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 40 (actual)

## Conditions studied

- Pharmacokinetic and Pharmacodynamic Profile of Tecarfarin

## Interventions

- **DRUG:** Tecarfarin 10mg
- **DRUG:** Tecarfarin 20mg
- **DRUG:** Tecarfarin 30mg
- **DRUG:** Tecarfarin 40mg

## Key facts

- **NCT ID:** NCT03652779
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-22
- **Primary completion:** 2019-10-28
- **Final completion:** 2019-10-28
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03652779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03652779, "A Study to Evaluate the Safety and Tolerability of Tecarfarin in Healthy Chinese Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03652779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*